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An alternative analysis of the complexes formed by Zr(IV) with acetohydroxamate shows that, in comparison
with the results reported in the title article, a more complicated complexation model is found, the stability
constants of the common complexes are considerably different and complexation of Zr(IV) does not show
any unusual behaviour.
The title article1 reported the crystal structure of the tetra-
chelated Zr(IV) complex Zr(Me-AHA)4 (Me-AHA = N-methyl
acetohydroxamate) along with the investigation of the solution
structures, performed by means of DFT calculations, and the
determination of the stability constants of the complexes
formed in solution by Me-AHA and its non-methylated analogue
AHA (acetohydroxamate). The crystal structure of Zr(Me-AHA)4,
showing Zr(IV) surrounded by four hydroxamates, evoked the
accessibility to a single ligand containing four hydroxamate
groups that is expected to be a better Zr(IV) chelator than desfer-
rioxamine B (DFO), a siderophore containing three hydroxamates
which is currently used for antibody radiolabeling with 89Zr in
nuclear medicine.
We recently came across the title article while we were
performing a study dealing with the speciation of the Zr(IV)
complexes with DFO in aqueous solution.2 The crystal structure
of the Zr(Me-AHA)4 complex is a key reference for the structure
of hyrdoxamate complexes with Zr(IV). While the structural
study in this paper appears to us of high quality and very
interesting, the stability constants of the Zr(IV) complexes
therein reported left us somewhat perplexed. According to this
paper, Zr(IV) can bind four AHA and Me-AHA ligands in succes-
sive steps for which the following equilibrium constants log Kn =
[MLn]/[MLn1][L] (L = AHA, Me-AHA, n = 1–4, charges of ligands
and complexes omitted through the text) were determined: for
AHA log K1 = 12.01, log K2 = 11.99, log K3 = 5.69, log K4 = 15.38;
for Me-AHA log K1 = 13.21, log K2 = 12.01, log K3 = 3.44, log K4 =
17.32. The ground of our first perplexity was the enormous
constants of the fourth equilibria (n = 4) that exceed all the
other ones, being up to 1010/1014 times higher than the third
ones. Instead, a steady decrease of Kn values with increasing
n would be normal, except for the very few cases in which the
metal–ligand bond energies change drastically as a function of
n. There are several reasons for this general trend, including
statistical factors, steric hindrance of the ligands if they are
bulkier than the replaced water molecules and electrostatic
factors that are very important for charged ligands.3 Among the
rare cases in which this trend undergoes an inversion at a certain
value of n, there are the complexes of Fe(II) with 1,10-
phenanthroline and 2,20-bipyridine as a consequence of the large
stabilization occurring for this d6 cation when the coordination of
the third ligand molecule transform the high spin bis-chelate
complexes into the low spin tris-chelate ones.4 The steady
decrease trend should instead be followed by Zr(IV), which has
no d electrons, especially when it forms complexes with charged
ligands like AHA and Me-AHA. As a matter of fact, this trend is
followed by AHA and Me-AHA complexes with several divalent and
trivalent transition metal ions,5 though they are not d0.
The experimental conditions adopted to determine the
stability constants of the ZrLn (n = 1–4) complexes, reported
in the title article, were another source of perplexity, since all
measurements were performed by using solutions containing
Zr(IV) and L in the 1 : 4 molar ratio; one might suspect that low
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substituted species such as ZrL and ZrL2 are unlikely to form
under such conditions. Indeed, the distribution diagrams of
the complex species formed by AHA and Me-AHA (see ESI† of
the title article) show that the ZrL4 complexes were practically
the only species present in the experimental solutions, apart
from the Zr(OH)4 complex that becomes prevalent in very
alkaline media. ZrL and ZrL2 are formed in less than 5% while
ZrL3 is not formed at all. It is intuitive, but it can also be proved
mathematically,6 that the stability constant of a complex in
solution can be determined by pH-metric methods only in the
case this complex affects the solution pH, which requires it is
formed in appreciable amounts.
Furthermore, it seems somewhat surprising that a metal ion
which forms highly hydrolysed species in solution, such as
Zr(OH)4, gives rise with AHA and Me-AHA only to complexes of
the type ZrLn (n = 1–4), none of which undergoes hydrolysis. In
other words, it seems somewhat surprising that the coordination
of a single AHA or Me-AHA bidentate ligand is enough for Zr(OH)4
to release all four OH anions. As a matter of fact, AHA does form
hydroxylated complexes with other metal ions, such as Ni(II), Cu(II)
and Zn(II),5 which are less prone than Zr(IV) to hydrolyse.
Then, considering the relevance of hydroxamate complexes of
Zr(IV) for nuclear medicine, we thought it would be useful to verify
the equilibrium data reported in the title article. To do this, six
potentiometric (pH-metric) titrations were performed on AHA/
Zr(IV) aqueous solutions, by using already described equipment
and methodology,7 and exploring Zr(IV) : AHA molar ratios ranging
from 1 : 1 to 1 : 8 in the pH range 2.3–11.2 (0.1 M Me4NCl, 298.1 K,
experimental details are given in the ESI†). A preliminary analysis
of this set of potentiometric data by means of the HYPERQUAD8
computer program showed that curves fitting was not possible by
using a model composed exclusively of the ZrLn (n = 1–4) com-
plexes. Introduction of hydroxylated species of ZrLn (n = 1–4)
complexes led to a good fitting of the acidic branches of the
potentiometric curves and to inclusion of [Zr(AHA)OH]2+ and
[Zr(AHA)(OH)2]
+ into the speciation model. Tentative to introduce
further mononuclear hydroxylated species did not help to fit the
alkaline branches of the curves. On the contrary, a complete and
satisfactory fitting of the six curves, over the entire pH range, was








or higher order oligomers, with no modification, within experi-
mental errors, of the stability constants of the other complexes
(see ESI†). Interestingly, these species are reminiscent of the Zr3 and
Zr6 clusters found in hydroxylated complexes of Zr(IV) containing
bridging chelate ligands and bridging (m2, m3) hydroxide anions.
9
The best fitting model (comprising [Zr3(AHA)3(OH)7]
2+ and
[Zr3(AHA)3(OH)8]
+) and the stability constants of the relative
complexes are reported in Table 1. According to the new
equilibrium data, AHA coordination to Zr(IV) does not show
any special behaviour, the binding of successive AHA ligand
molecules following the expected trend of decreasing equilibrium
constants, in analogy with the behaviour previously found
for other metal ions such as Ni(II), Zn(II) and Fe(III) (Fig. 1).
Furthermore, Fig. 1 shows that a normal trend of increasing
stability with increasing metal ion charge applies to the equally
substituted AHA complexes of these metal cations.
In conclusion, the new data, obtained in compliance of recom-
mended rules for the determination of stability constants,6,10–12
offer an alternative speciation of the complexes formed by Zr(IV)
with AHA, show that this metal ion has no special properties in the
formation of hydroxamate complexes, confirm that it is able to
bind four hydroxamate groups in solution, although with a normal
decreasing ability in the successive steps, and confirm that poten-
tiometry, when adequately used, can be a good method for studying
complexation equilibria of even challenging metal cations such as
Zr(IV). The new equilibrium data complement the key structural
information reported in the title article.
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